231 related articles for article (PubMed ID: 33324362)
1. Engineered Lysins With Customized Lytic Activities Against Enterococci and Staphylococci.
Binte Muhammad Jai HS; Dam LC; Tay LS; Koh JJW; Loo HL; Kline KA; Goh BC
Front Microbiol; 2020; 11():574739. PubMed ID: 33324362
[TBL] [Abstract][Full Text] [Related]
2. Construction of a chimeric lysin Ply187N-V12C with extended lytic activity against staphylococci and streptococci.
Dong Q; Wang J; Yang H; Wei C; Yu J; Zhang Y; Huang Y; Zhang XE; Wei H
Microb Biotechnol; 2015 Mar; 8(2):210-20. PubMed ID: 25219798
[TBL] [Abstract][Full Text] [Related]
3. Exploiting Broad-Spectrum Chimeric Lysin to Cooperate with Mupirocin against Staphylococcus aureus-Induced Skin Infections and Delay the Development of Mupirocin Resistance.
Duan XC; Li XX; Li XM; Wang S; Zhang FQ; Qian P
Microbiol Spectr; 2023 Jun; 11(3):e0505022. PubMed ID: 37125939
[TBL] [Abstract][Full Text] [Related]
4. A Novel
Cater K; Dandu VS; Bari SM; Lackey K; Everett GF; Hatoum-Aslan A
mSphere; 2017; 2(2):. PubMed ID: 28357414
[TBL] [Abstract][Full Text] [Related]
5. Sequence-Function Relationships in Phage-Encoded Bacterial Cell Wall Lytic Enzymes and Their Implications for Phage-Derived Product Design.
Vázquez R; García E; García P
J Virol; 2021 Jun; 95(14):e0032121. PubMed ID: 33883227
[TBL] [Abstract][Full Text] [Related]
6. Novel Phage Lysin Abp013 against
Chu JJK; Poh WH; Hasnuddin NTB; Hew EY; Dam LC; Sahili AE; Rice SA; Goh BC
Antibiotics (Basel); 2022 Jan; 11(2):. PubMed ID: 35203772
[TBL] [Abstract][Full Text] [Related]
7. Role of net charge on catalytic domain and influence of cell wall binding domain on bactericidal activity, specificity, and host range of phage lysins.
Low LY; Yang C; Perego M; Osterman A; Liddington R
J Biol Chem; 2011 Sep; 286(39):34391-403. PubMed ID: 21816821
[TBL] [Abstract][Full Text] [Related]
8. Structural and biochemical analyses of the tetrameric cell binding domain of Lys170 from enterococcal phage F170/08.
Xu X; Zhang D; Zhou B; Zhen X; Ouyang S
Eur Biophys J; 2021 Jul; 50(5):721-729. PubMed ID: 33609147
[TBL] [Abstract][Full Text] [Related]
9. PL3 Amidase, a Tailor-made Lysin Constructed by Domain Shuffling with Potent Killing Activity against Pneumococci and Related Species.
Blázquez B; Fresco-Taboada A; Iglesias-Bexiga M; Menéndez M; García P
Front Microbiol; 2016; 7():1156. PubMed ID: 27516758
[TBL] [Abstract][Full Text] [Related]
10. Identification of Three Campylobacter Lysins and Enhancement of Their Anti-Escherichia coli Efficacy Using Colicin-Based Translocation and Receptor-Binding Domain Fusion.
Liu P; Dong X; Cao X; Xie Q; Huang X; Jiang J; Dai H; Tang Z; Lin Y; Feng S; Luo K
Microbiol Spectr; 2023 Feb; 11(2):e0451522. PubMed ID: 36749047
[TBL] [Abstract][Full Text] [Related]
11. Molecular dissection of phage lysin PlySs2: integrity of the catalytic and cell wall binding domains is essential for its broad lytic activity.
Huang Y; Yang H; Yu J; Wei H
Virol Sin; 2015 Feb; 30(1):45-51. PubMed ID: 25680444
[TBL] [Abstract][Full Text] [Related]
12. Lysocins: Bioengineered Antimicrobials That Deliver Lysins across the Outer Membrane of Gram-Negative Bacteria.
Heselpoth RD; Euler CW; Schuch R; Fischetti VA
Antimicrob Agents Chemother; 2019 Jun; 63(6):. PubMed ID: 30962344
[TBL] [Abstract][Full Text] [Related]
13. Engineering a Lysin with Intrinsic Antibacterial Activity (LysMK34) by Cecropin A Fusion Enhances Its Antibacterial Properties against Acinetobacter baumannii.
Abdelkader K; Gutiérrez D; Tamés-Caunedo H; Ruas-Madiedo P; Safaan A; Khairalla AS; Gaber Y; Dishisha T; Briers Y
Appl Environ Microbiol; 2022 Jan; 88(1):e0151521. PubMed ID: 34669452
[TBL] [Abstract][Full Text] [Related]
14. Engineered bacteriophage lysins as novel anti-infectives.
Yang H; Yu J; Wei H
Front Microbiol; 2014; 5():542. PubMed ID: 25360133
[TBL] [Abstract][Full Text] [Related]
15. Rapid and High-Throughput Evaluation of Diverse Configurations of Engineered Lysins Using the VersaTile Technique.
Duyvejonck L; Gerstmans H; Stock M; Grimon D; Lavigne R; Briers Y
Antibiotics (Basel); 2021 Mar; 10(3):. PubMed ID: 33799561
[TBL] [Abstract][Full Text] [Related]
16. Gram-Negative Bacterial Lysins.
Ghose C; Euler CW
Antibiotics (Basel); 2020 Feb; 9(2):. PubMed ID: 32054067
[TBL] [Abstract][Full Text] [Related]
17. Bacteriophage φEf11 ORF28 Endolysin, a Multifunctional Lytic Enzyme with Properties Distinct from All Other Identified Enterococcus faecalis Phage Endolysins.
Zhang H; Buttaro BA; Fouts DE; Sanjari S; Evans BS; Stevens RH
Appl Environ Microbiol; 2019 Jul; 85(13):. PubMed ID: 30979842
[TBL] [Abstract][Full Text] [Related]
18. Development of Phage Lysin LysA2 for Use in Improved Purity Assays for Live Biotherapeutic Products.
Dreher-Lesnick SM; Schreier JE; Stibitz S
Viruses; 2015 Dec; 7(12):6675-88. PubMed ID: 26694451
[TBL] [Abstract][Full Text] [Related]
19. A novel chimeric phage lysin with high in vitro and in vivo bactericidal activity against Streptococcus pneumoniae.
Díez-Martínez R; De Paz HD; García-Fernández E; Bustamante N; Euler CW; Fischetti VA; Menendez M; García P
J Antimicrob Chemother; 2015; 70(6):1763-73. PubMed ID: 25733585
[TBL] [Abstract][Full Text] [Related]
20. Internal cell-penetrating peptide-mediated internalization enables a chimeric lysin to target intracellular pathogens.
Yang H; Xu J; Gong Y; Tang Y; Li W; Zheng Z; Li Y; He J; Wei H
Int J Pharm; 2021 Apr; 599():120449. PubMed ID: 33711472
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
